Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Misys Laboratory System Versions 5.2, 5.23 and 5.3

FDA Recall Z-0614-03 · Posted 2003-03-06

Recalling FirmMisys Healthcare Systems
Recall StatusTerminated
Product CodeJQP
Date Initiated2003-01-31
Date Terminated2004-05-07
Product Quantity542

Reason for Recall

Software anomaly. Rejecting the selected Autofiling status may result in the change being accepted rather than rejected.

Firm Action

Firm sent notice by FAX on 1/31/2003. A workaround provided should prevent the problem until a software fix is made available. Clients can expect a notice when this is made available.

Root Cause

Other

Distribution Pattern

Nationwide and to United Kingdom, Canada, Denmark, Ireland, Bermuda, Saudi Arabia, United Arab Emirates.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑